OpenAlex
PricingAboutJobs
Log inGet started
Work

Bromodomains: a new target class for drug development

HTML

Year: 2019
Type: review
Source: Nature Reviews Drug Discovery
DOI: 10.1038/s41573-019-0030-7
Authors: Andrea G. Cochran, Andrew R. Conery, Robert J. Sims
Institutions: Genentech, Constellation Pharmaceuticals (United States)
Language: English

Topic: Protein Degradation and Inhibitors
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: bromodomain inhibitors, BET inhibitors, epigenetic reader protein, protein-protein interaction domains, chemical probes, anticancer drug development, anti-inflammatory agents, clinical development
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2953873379
FWCI: 5.546
Cites: 265
Cited by: 455
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms